First Annual Brain and Behavior Symposium:
The Future of the Brain

Brookside Institute is at the forefront of substance abuse treatment, applying over twenty years of research to develop the Brookside Recovery Protocol ™, a science-based medical model for treating addiction and co-occurring disorders (dual diagnosis). The Brookside Recovery Protocol ™ uses a four-part recovery protocol that includes Cognitive Behavioral Therapy (CBT), addiction medications, brainwave analysis and treatment, and adjunctive therapy. We constantly review each treatment modality and incorporate diagnostic tools to continually create the most effective, science validated addiction treatment protocol.

As part of our continual analysis of new treatments and breakthroughs in brain-based diseases, Brookside Institute is pleased to announce our first annual Brain and Behavior Symposium: The Future of the Brain.

This symposium highlights three exciting fields in neuroscience with treatment applications for learning disabilities, ADHD, PTSD, brain injuries and trauma, memory disorders (Alzheimer’s) and substance abuse.

Moderator: Max A. Schneider, M.D., FASAM
Watch Video

Max A. Schneider, M.D., FASAM, Director of Education, Positive Action Center at Chapman Medical Center, Orange, California, is Director of Addiction Medicine Affairs at CNS Response, a Fellow and past president of the American Society of Addiction Medicine (ASAM), a Past Chair and current Member of the Board of Directors of the National Council on Alcoholism and Drug Dependence (NCADD), a past consultant to the Drug and Alcohol Advisory Committee of the U.S. Food and Drug Administration and a former Certified Medical Review Officer. Educated at the University of Buffalo School of Medicine and Harvard Medical School, he has been active in the field of addiction medicine since 1953 and currently serves as a Clinical Professor in the Department of Family Medicine (Addiction Medicine) at the University of California at Irvine College of Medicine. He has produced ten films and five booklets on addiction; authored over 60 papers and has lectured in 49 states, three Canadian provinces and six countries. In 1995 he was named "Doctor of the Year" by the Orange County Medical Association and presented the "Golden Apple Award" for outstanding teaching by the 1995 University of California at Irvine Medical College graduating class.

Referenced Electroencephalography (rEEG) presented by Daniel A. Hoffman, M.D., Neuropsychiatry, National Regional Medical Director, CNS Response, Inc.
Watch Video

This presentation reviews the ability to predict psychotropic medication response through a new technology known as Referenced-EEG. Various uses of quantitative EEG are emerging as possible ways to predict positive and adverse responses to medications prescribed to treat psychiatric disorders. By relying on physiologic predictors, such as EEG biomarkers, instead of solely on a patient’s reported symptoms, psychiatrists can identify the most effective treatment for the individual patient.

With rEEG, the physician receives a report listing the drug classes, subclasses and individual medications ranked in probability of treatment success based on database-recorded patient outcomes associated with the physiologic features of the patient’s quantitative EEG.

Dr. Hoffman holds the position of Medical Director for the Neuro-Therapy Clinic, P.C. since 1991, as well as the National Regional Medical Director for CNS Response, Inc. since 2004. He has been active in his field of Neuropsychiatry and Behavioral Medicine for Cognitive Defects since graduating from Wayne State University School of Medicine in Michigan and the University of Michigan. Having held numerous positions within his field, including Chief Resident at the Adult Outpatient Clinic at the University of Colorado Health Science Center (formerly University of Colorado Medical Center), Dr. Hoffman continues his work as Reviewing Editor, Journal of Applied Psychophysiology and Self Regulation (formerly, Journal of Biofeedback and Self Regulation). With more than 30 publications to his credit, Dr. Hoffman is continuing his work in Neuropsychiatry and Behavioral Medicine for Cognitive Deficits, and Computer Enhanced or Quantitative Electroencephalography (QEEG) and EEG Neurofeedback for Closed Head Injury, Seizures, and Attentional and Learning Disorders.

NeuroGeniSys Procedure (Neuro Cognitive Development and Rehab) presented by Curtis Cripe, Ph.D., Director and Founder of Crossroads Institute and Centers
Watch Video

Dr. Cripe presents findings in the emerging NeuroGeniSys Systems field to treat ADD/ADHD, depression, PTSD and addiction disorders. The purpose of the NeuroGeniSys therapies is to normalize the areas of the brain that are exhibiting abnormal EEG patterns, identified by the qEEG and fqEEG (Quantitative EEG and Functional QEEG). These brain areas are involved with poor overall brain performance as exhibited in attentional issues, mood regulation issues and addiction disorders.

The results of combining several cognitive rehabilitation techniques with modern neurodevelopment methods will be presented. One such therapy, the Low Energy Neurofeedback System (LENS), uses an electromagnetic field as the carrier wave for the feedback. With this method, the EEG leads serve as bi-directional conduits for both the brainwaves and the feedback signals.

Curtis T. Cripe, holds a Ph.D. in research psychology with emphasis in neuropsychology, neurodevelopment and psychophysiology as well as a Masters in Aerospace engineering. He is board certified in Neurodevelopment, Neurotherapy and a Diplomat in Peak Performance. Due to his early professional years as a top aerospace engineer for NASA’s Jet Propulsion Laboratory, Dr. Cripe understands the need for precision and gained an appreciation for concrete science based (objective) measures. As a leader in the field of Neurocognitive Development, Curtis Cripe has worked over the past 25 years with the brain and how to overcome limitations to reaching full brain potential. Curtis Cripe is Director and Founder of Crossroads Institute and Centers with 10 locations in Arizona, Texas, Florida, Virginia, and California.

Repetative Transcranial Magnetic Stimulation (rTMS) presented by Yi Jin, M.D. Electrophysiologist, Director of NeuroScience Center, Brookside Institute
Watch Video

Transcranial magnetic stimulation (TMS) is a noninvasive method to excite neurons in the brain. The excitation is caused by weak electric currents induced in the tissue by rapidly changing magnetic fields (electromagnetic induction). This way, brain activity can be triggered or modulated without the need for surgery or external electrodes.

Repetitive TMS can be used to study how the brain organizes different functions such as language, memory, vision, or attention. In addition, rTMS may be used to change the activity in a brain area even beyond the duration of the rTMS application itself. In other words, rTMS makes a given brain area work more or less for a period of minutes, hours, days or even weeks when rTMS is applied repeatedly several days in a row. This has opened up the use of rTMS for therapy of some illnesses in neurology and psychiatry including major depression, bipolar affective disorder, general anxiety, sleep disorder, substance abuse with co-occurring disorders (dual diagnosis), autism, and certain types of learning disabilities.

Dr. Jin is an electrophysiologist with over 20 years of experiences in clinical and psychiatric research. His specialty in electroencephalogram (EEG) is particularly suitable to the work at Brookside Institute. His electrophysiological works have been extended to the studies of neural perceptual coding, mental disorders, substances abuse, genetics, and psychopharmacology. Dr. Jin is director of Behavioral EEG Lab of the Department of Psychiatry at the University of California, Irvine. He is also an executive board member of the EEG & Clinical Neuroscience Society (ECNS).

Applying Breakthroughs in Neuroscience to treat Addiction and Co-Occurring Disorders through the Brookside Recovery Protocol™ presented by Trung Minh Thai, M.D., Psychiatrist, Medical Director, Brookside Institute
Watch Video

Dr. Thai will speak about Brookside Institute’s continuing dedication in bringing new science-based treatments and therapies for addiction and co-occurring disorders into the Brookside Recovery Protocol™ including Referenced Electroencephalography (rEEG), Neurodevelopment and Repetative Transcranial Magnetic Stimulation (rTMS).

Dr. Thai has spent the past ten years working with patients who suffer from anxiety, PSTD, depression, Alzheimer's disease, schizophrenia, and other mental health disorders. He brings a wealth of experience in dual diagnosis, pharmacology, and mental health disorders to Brookside Institute. Dr. Thai is an associate clinical professor at UCI Medical Center and has co-authored many groundbreaking research papers on mental health disorders, including the effects of Transcranial Magnetic Stimulation (TMS) on certain psychiatric conditions. In recent years, Dr. Thai has served on the Orange County Mental Health Board and on the UCI Credential Committee.